Accéder au contenu
Merck

[Pharmacological treatment of spasticity in multiple sclerosis].

Revue neurologique (2012-06-29)
O Heinzlef, I Monteil-Roch
RÉSUMÉ

The medicinal treatment of spasticity includes use of oral treatments (baclofène and tizanidine), botulinum toxin, intrathecal baclofène and local application of alcohol or phenol. However, spasticity may not be uncomfortable and may even be useful. Therefore, all spastic diseases do not systematically require treatment. First-line treatments (oral treatments and botulinum toxin) can be considered depending on the local or diffuse nature of the spasticity and depending on the etiology.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(±)-Vigabatrin
Supelco
Vigabatrin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®